Related Experiment Video

Updated: Aug 16, 2026

A Mouse 5/6th Nephrectomy Model That Induces Experimental Uremic Cardiomyopathy
07:52

A Mouse 5/6th Nephrectomy Model That Induces Experimental Uremic Cardiomyopathy

Published on: November 7, 2017

Kidney disease and cardiovascular disease: implications of dyslipidemia

William F Keane1, Paulette A Lyle

  • 1US Human Health, Merck & Co., Inc., 351 N. Sumneytown Pike, UG4A-025, North Wales, PA 19454, USA. williamf_keane@merck.com

Cardiology Clinics
|August 9, 2005
PubMed

Insights

Managing lipid levels in kidney disease patients is crucial for reducing cardiovascular risks. Further research is needed to determine if lipid regulation impacts the progression of kidney disease itself.

Area of Science:

  • Nephrology
  • Cardiology
  • Clinical Medicine

Background:

  • Cardiovascular complications are prevalent in patients suffering from kidney disease.
  • Dyslipidemia is a significant concern in this patient population.
  • Effective management of lipid levels is essential for mitigating health risks.

Purpose of the Study:

  • To summarize the importance of lipid regulation in kidney disease patients.
  • To highlight the known benefits of lipid management on cardiovascular events.
  • To identify the knowledge gap regarding lipid regulation's effect on kidney disease progression.

Main Methods:

  • Review of existing literature on dyslipidemia and kidney disease.
  • Analysis of studies focusing on cardiovascular outcomes in kidney disease patients undergoing lipid management.
  • Identification of research addressing the impact of lipid regulation on renal function decline.

Main Results:

  • Lipid regulation demonstrably decreases the incidence of coronary vascular events and other vascular complications in patients with kidney disease.
  • The effect of lipid regulation on the slowing of kidney disease progression remains undetermined.
  • Current evidence underscores the need for further investigation into dyslipidemia's role in kidney disease.

Conclusions:

  • Lipid management is vital for reducing cardiovascular morbidity in kidney disease.
  • The impact of lipid-lowering therapies on the progression of kidney disease requires further extensive research.
  • Understanding the full implications of dyslipidemia in nephrology patients is critical for comprehensive care.

Related Concept Videos

Chronic Kidney Disease II: Clinical Manifestations01:24

Chronic Kidney Disease II: Clinical Manifestations

Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
Chronic Kidney Disease I: Introduction01:25

Chronic Kidney Disease I: Introduction

Chronic Kidney Disease (CKD) arises when the kidneys progressively lose their ability to function, ultimately leading to end-stage renal disease. At this advanced stage, the kidneys can no longer filter waste or maintain essential body functions, requiring renal replacement therapy (RRT) through dialysis or a kidney transplant for survival.Early-stage chronic kidney disease and detection challengesIn CKD's early stages, symptoms often remain absent because healthy nephrons compensate for...
Diabetic Nephropathy01:28

Diabetic Nephropathy

Definition Diabetic nephropathy is a chronic kidney complication that results from prolonged hyperglycemia.Prevalence It is the most common cause of chronic kidney disease (CKD) and end-stage renal disease (ESRD) worldwide, affecting up to half of individuals with diabetes.Pathophysiology • Sustained hyperglycemia triggers multiple hemodynamic and metabolic changes in the kidney. • Early in the disease, increased renal blood flow and glomerular hyperfiltration occur due to afferent arteriolar...
Chronic Kidney Disease IV: Nursing Management01:18

Chronic Kidney Disease IV: Nursing Management

Nursing management is essential for preventing complications, maintaining stability, and improving patients' quality of life in chronic kidney disease (CKD). By using a structured approach, nurses help slow CKD progression and support effective patient care​.1. Comprehensive patient assessmentEffective management begins with nurses reviewing the patient’s medical history, and identifying key risk factors like diabetes, hypertension, and nephrotoxic drug use. Nurses assess signs of fluid...
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...